Nevertheless, another study has identified a unique CD8+T-cell blood/tumor-shared subpopulation in melanoma patients with high levels of oxidative phosphorylation, which is correlated with immune checkpoint inhibitor (ICI) resistance in melanoma patients. Here, CD8A is linked to melanoma.